VCM
GSK icon

Violich Capital Management’s GSK GSK Stock Holding History

Violich Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,348
Closed -$291K – 103
2014
Q2 		$291K Buy
4,348
+120
+3% +$8.12K 0.1% 84
2014
Q1 		$282K Sell
4,228
-160
-4% -$10.8K 0.1% 80
2013
Q4 		$293K Sell
4,388
-3,140
-42% -$204K 0.11% 83
2013
Q3 		$472K Sell
7,528
-680
-8% -$43.8K 0.18% 70
2013
Q2 		$513K Buy
+8,208
New +$521K 0.21% 69

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Violich Capital Management's GSK Position: Q3 2014 in Review

Violich Capital Management sold out of GSK (GSK) in Q3 2014, closing a stake of 4,348 shares — an estimated $291K sold.

Violich Capital Management first reported a position in GSK in Q2 2013 and held it in 5 quarters. The position peaked at $513K in Q2 2013. 702 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

  • Violich Capital Management reported no remaining GSK position as of Q3 2014 after selling out during the quarter.
  • Violich Capital Management sold 4,348 GSK shares in Q3 2014, an estimated $291K.
  • Violich Capital Management first reported a position in GSK in Q2 2013 and held it in 5 quarters.
  • Violich Capital Management's GSK position peaked at $513K in Q2 2013.
  • 702 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on Violich Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.